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Introduction 
Squamous cell carcinoma of the head and neck is one 
of the most common malignancy worldwide, accounting 
for nearly 6% of all cancer cases and with an increased 
incidence rate in middle-aged and elderly males worldwide 
(1-4). Several treatment approaches have been proposed for 
head and neck cancer, based on clinical stage and patient’s 
conditions. They include surgery, chemoradiotherapy and, 
for selected cases, electrochemotherapy (4-11). Surgery is 
usually considered the first approach; however, upper airway 
stenosis caused by neoplastic diseases, such as tumors of the 
larynx, pharynx and base of the tongue, is associated with 
difficult perioperative airway management and a higher 
level of discomfort (12, 13). In these patients, mechanical 
obstruction can complicate the ventilation and intubation 
due to tumor mass compression (14, 15), loss of pharyngeal 
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muscles tone and the collapse of the upper airway after neu-
romuscular blocking drugs injection potentially leading to 
“Can’t Intubate Can’t Oxygenate” (16). As in other subsets 
of patients, when difficult intubation is anticipated the use 
of awake fiberoptic intubation (AFOI) is the safest option, 
despite available algorithms for difficult airway management 
do not provide specific guidelines for the management of 
patients with neoplastic upper airway obstruction (17-19).
The association of superior laryngeal nerve block 
(SLNB) to systemic sedation has been proposed for AFOI; 
however, there are no evidences of benefits for this asso-
ciation in patients undergoing upper airways oncological 
surgery (20-24). 
Aim of this prospective randomized study is to evaluate 
in patients undergoing upper airway oncological surgery the 
safety and efficacy of the association of systemic sedation 
with SLNB for AFOI. Recorded variables include occurrence 
of complication, patients’ comfort and the time necessary 
to intubate.  
Methods
Patients and Study Design
A non-selected series of 40 consecutive patients, aged 
>18 years, undergoing elective AFOI for upper airway neo-
plastic obstruction were prospectively enrolled.  Exclusion 
criteria were any of the following: patients with respiratory 
tirage and cornage; Arnè multifactorial scale < 11 (25). The 
study was approved by Ethical Committee of our University 
Hospital (406/17). All study participants gave informed writ-
ten consent and the research was conducted in accordance 
with the Helsinki Declaration.
Awake fiberoptic intubation procedure and endpoint 
evaluation
After the first measurement of vital parameters (T0) 
for AFOI, all patients received a continuous infusion of 
remifentanil at a rate ranged between 0.05 and 0.15 mcg/
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kg/min, reaching by titration of a conscious sedation plane 
corresponding to the 0/-1 stage of the Richmond Agitation-
Sedation Scale (RASS). In all patients of both groups, topical 
anesthesia of the oropharynx mucosa was performed through 
10 puffs of 10% lidocaine spray at the back of the tongue 
and at the base of the palatopharyngeal and palatoglossal 
arch; in addition, an intercricoid block was performed by 
translaryngeal puncture and 4 ml of lidocaine 1.5%. Patients 
were randomized into two groups: patients undergoing 
SNLB with 4 ml of 1.5% lidocaine (study group, L-SNLB) 
and patients that received SNLB with saline (control group, 
S-SNLB). After regional anesthesia, the patient was placed 
on the operating table with the head in a neutral position. 
The vital parameters and the level of sedation reached (T1) 
were registered. If SpO2 was less than 96%, the patient was 
pre-oxygenated with FiO2 100%. The AFOI procedure was 
performed using a 4 mm Olympus LF-2 bronchoscope and 
spiral tracheal tubes (internal diameter of between 5-6 mm) 
were used. Discomfort during AFOI was evaluated through 
the Fiber Optic Intubation Comfort Score (Table 1). 
During the AFOI procedure, unstructured airway maneu-
vers (neck’s hyperextension, jaw subluxation, and pulling 
the tongue manually) were evaluated. Hypoxemia, aspiration 
of secretions and time to perform intubation were reported. 
After intubation, a new evaluation of the vital parameters was 
performed (T2) and patients underwent to a total intravenous 
general anesthesia in accordance with the current interna-
tional protocols. The primary endpoint was to evaluate the 
capability of SLNB to reduce the degree of discomfort of 
the AFOI procedure measured with the relative risk of Fiber 
Optic Intubation Comfort Score > 1. Secondary endpoints 
were incidence of hypoxemia, time required to intubate, 
intraprocedural hemodynamic stability, airway obstruction 
score, need to aspirate secretions during AFOI, Tracheal 
Tube Tolerance Score.
 
Statistical analysis
The primary endpoint was analyzed using the Chi-square 
test. Secondary endpoints were evaluated using survival 
analysis techniques (Kaplan-Meier estimator, Cox model), 
logistic models and multiple regression models possibly 
after the Box-Cox transformation of the outcome. For the 
analysis of the time to intubation, the quantile regression 
was used. All tests were two-tailed. The primary endpoint 
was the comparison of the Fiber Optic Intubation Comfort 
Score > 1 between the two groups. Based on case studies 
in the literature and our personal experience, we assumed 
that in the absence of the SLNB there is about 80% of Fiber 
Optic Intubation Comfort Score (FOICS) > 1, while this 
percentage drops to 50% with the laryngeal block. Therefore, 
against a chi-square test level of 5%, 39 subjects guarantee 
a power of 90%.
Results
Forty patients (20 for each group) were recruited and 
completed the study. Demographic characteristics (age, 
gender, weight, ASA-PS and Arnè scale) were comparable 
between 2 groups (Table 2). 
In all patients, the level of systemic sedation was adequa-
te (RASS < 1) during AFOI [L-SNBP 18 (90%) and S-SNBP 
19 (95%) (P = 0.51)]. Cough score differed between patients 
assigned to the two treatment groups (20/20 in L-SNBP 
achieved cough score ≤2 and 14/20 in S-SNBP: p=0.007). 
Patients assigned to L-SNBP reported a higher comfort and 
better tolerance to endotracheal tube: fiberoptic intubation 
score was 1 in 18 (90%) patients in the L-SNBP group and 
in 2 (10%) patients of S-SNBP group (p<0.001); tracheal 
1- No reactions, collaborating patient
2- Slight facial movements
3- Vigorous facial movements
4- Verbal op position
5- Movements of head and arms
Table 1. Fiber Optic Intubation Comfort Score
Fiber Optic Intubation Comfort Score used to evaluate discomfort 
during the procedure
L-SLNB S-SLNB p-value
Gender Male 11 (55%) 12 (60%) 1
Female 9 (45%) 8 (40%)
Age mean (SD) 64.95 (±12.05) 59.65 (±16.3) 0.25
Me (Q1,Q3) 67.5 (59.5,75.5) 60.5 (47.7,75.2)
Height mean (SD) 166.5 169.0 0.914
Me (Q1,Q3)  (162.2,173.5)  (163.7,174.2)
Weight mean (SD) 69.75 (±10.24) 72.25 (±11.88) 0.481
Me (Q1,Q3) 67.5 (62.5,78.2) 69.0 (66.0,77.0)
RASS -1 6 (30%) 3 (15%) 0.511
0 12 (60%) 16 (80%)
1 2 (10%) 1 (5%)
Table 2. Demographic characteristics of the group population
Results are showed as mean and median (Me) [Quartiles]. RASS (Richmond Agitation-Sedation Scale)
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tube tolerance score was 1 in 14 (70%) patients of L-SNBP 
group and 5 (25%) of S-SNBP group (p=0.003). Patients 
in the L-SNBP group required a shorter time for intubation 
compared to patients in the S-SNBP group [47.45 sec vs 
80.15 (p<0.01)] (Table 3). 
No complications were recorded in studied patients; all 
patients maintained SpO2 ≥ 95% during the procedure, none 
required additional O2 therapy and jaw thrust maneuver. 
Baseline arterial blood pressure, HR and SpO2 were 
comparable throughout the procedures in the two study 
groups. No significant changes were reported in hemody-
namic variables during and after the procedure at T0 to T2 
(Table 4).
Discussion
In this prospective randomized controlled study, we ori-
ginally tested the safety and efficacy of L-SLNB in associa-
tion with systemic sedation for AFOI in patients undergoing 
oncological upper airway surgery and recorded a better 
comfort status and a shorter time to intubation in patients 
that received L-SLNB. These results are consistent with 
Fiberoptic Intubation Confort scale 1 18 (90%) 2 (10%) <0.001
2 2 (10%) 12 (60%)
3 0 (0%) 5 (25%)
4 0 (0%) 1 (5%)
Obstruction score 1 17 (75%) 2 (10%) 0,007
2 3 (15%) 12 (60%)
3 0 (0%) 5 (25%)
4 0 (0%) 1 (5%)
Cough 1 17 (75%) 12 (60%) 0,035
2 3 (15%) 7 (30%)
3 0 (0%) 2 (10%)
Need for suction Yes 4 (20%) 7 (35%) 0,479
No 16 (80%) 13 (65%)
Tracheal tube tollerance score 1 14 (70%) 5 (25%) 0,003
2 6 (30%) 12 (60%)
3 0 (0%) 3 (15%)
Duration of the procedure (sec) mean (SD) 47.45 (±15.38) 80.15 (±37.91) <0.001
Me (Q1,Q3) 45.0 (39.5,58.2) 79.0 (61.0,90.0)
Results are showed as mean and median (Me) [Quartiles]. RASS (Richmond Agitation-Sedation Scale)
Table 3. Outcomes of anesthesiology procedure
Table 4. Hemodynamic  parameters
SAP  T0 SAP  T1 SAP T2
L-SLNB 152.8 (±12.53) 146.7 (±14.7) 151.1 (±14.02)
S-SLNB 165.3 (±22.58) 158.2 (±25.34) 163.9 (±26.42)
DAP T0 DAP T1 DAP T2
L-SLNB 77.95 (±5.69) 73.75 (±10.04) 77.25 (±9.93)
S-SLNB 83.3 (±13.79) 76.9 (±13) 80.45 (±12.04)
MAP T0 MAP T1 MAP T2
L-SLNB 102.65 (±6.25) 97.75 (±9.55) 101.65 (±9.57)
S-SLNB 110.45 (±15.03)
103.65 
(±14.82) 108 (±15.72)
HR T0 HR T1 HR T2
L-SLNB 77.5 (±11.21) 75.1 (±12.38) 82.4 (±10.35)
S-SLNB 76.25 (±9.74) 74.2 (±10.8) 86.2 (±14.24)
SpO2 T0 SpO2 T1 SpO2 T2
L-SLNB 97 (±1.55) 95.1 (±3.11) 96.7 ± (1.94)
S-SLNB 97.65 (±1.42) 95.55 (±1.87) 97.6 (±1.84)
L-SLNB Lidocaine- Superior Laryngeal Nerve Block; S-SLNB 
Saline- Superior Laryngeal Nerve Block. SAP Sistolyc Arterial 
Pressure; MAP: Mean Arterial Pressure; DAP:  Diastolic Arterial 
Pressure; HR: heart rate
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previous evidence in other subset of patients (21, 26-29). 
In an observational study of 50 patients, undergoing AFOI, 
the association of the SLNB to the laryngeal cricothyroid 
block improved the visualization of the airway, limited the 
appearance of coughing and vomiting, and reduced the time 
of the intubation compared to the local anesthesia of the air-
way (26). In 48 patients with difficult airway undergoing to 
nasotracheal awake intubation, but without obstructive lesion 
of the upper airway, Kundra et al reported that the SLNB 
added to the translaryngeal block improved the patient’s 
comfort. The SLNB limited hemodynamic instability com-
pared to the group of patients managed with topical airway 
anesthesia (4% lidocaine nebulization) (28). In a previous 
study, Reasoner et al divided 40 neurosurgical patients with 
cervical spine instability into two groups: the first group 
treated with nebulization of 4% lidocaine, the second group 
with bilateral block of glossopharyngeal and SLNB; in all 
patients a 4% lidocaine solution was administered via the 
transcricoid route. In contrast to previous studies, the authors 
found no differences in the two groups regarding discom-
fort and hemodynamic alterations; however, the first group 
required an average double dose of lidocaine. None of the 
subjects enrolled was a carrier of obstructive lesion of the 
upper airway (29).
The SLNB could reduce both the risk of oversedation 
and the dose of local anesthetics (21). Systemic sedation 
can reduce the muscle tone of the upper airway, decreases 
the caliber and promotes obstruction at the supraglottic 
level; oversedation causes respiratory depression, apnea 
and in patients with obstruction of the airway exacerbates 
the pre-existing obstruction up to the complete occlusion 
of the airway (30). In oncological upper airway patients, if 
local anesthesia is inadequate and insufficient, mechanical 
stimulation of the mucosa by the fiberscope promotes edema 
and laryngospasm, compromising the visualization of laryn-
geal activity and success of the procedure. Furthermore, the 
application of local anesthetic in subjects with obstruction 
of the airway worsens the obstruction until the complete 
closure of the airway with dramatic outcomes (31). 
In our study, we have decided to select FOICS: a sim-
plified score of the Observers’ Assessment of Alertness/
Sedation (OAA/S) and Comfort Scale, to evaluate patient’s 
discomfort during the introduction of the fiberscope (32). A 
low dose of remifentanil maintained in all patients a slight 
sedation (RASS < 1), so patients were able to collaborate. 
They were treated with local anesthesia and intercricoid 
block; furthermore, in patients in the L-SNLB group intu-
bation resulted a significantly more comfortable procedure 
compared to patients in the S-SNLB group (90% of patients 
in the L-SNLB group had a FOICS ≤ 1, compared to 10% 
in the S-SNLB group). In these patients, the reactivity of 
the intrinsic laryngeal musculature is often elicited by the 
presence of edema and inflammation of the mucosa, which 
on the one hand limit the effectiveness of the topic anesthetic 
and on the other accentuate the intensity of the protective 
reflexes of the airway. 
In our study, the SLNB also improved patient’s tolerance 
to the presence of the endotracheal tube measured through 
the Tracheal Tube Tolerance Score scale. This result shows 
how anesthesia of the territory of this nerve can help limiting 
the reactivity of the upper airways. Cough score ≤ 2 was ano-
ther parameter favoring intubation. The control of laryngeal 
reactivity also favors the patency of the upper airway during 
the introduction of the fiberscope and could explain the les-
ser use of unblocking airway maneuvers during intubation 
procedure in patients undergoing SLNB. 
The control of laryngeal reflexivity, anesthesia in the 
area of  distribution of the upper airways and the reduction 
of discomfort favored patient’s collaboration, improving the 
time to intubation of patients undergoing SLNB. The mean 
time taken for AFOI was significantly less in the L-SLNB 
respect to the S-SLNB.
None of the patients reported desaturation or other 
adverse events during the intubation procedure. This data 
highlights the block’s safety in the AFOI scenario. One limit 
of this study is that we performed SLNB with landmark 
technique despite it is demonstrated that ultrasound improves 
quality of airway anesthesia and patient tolerance.
Conclusions
Our study showed that the association of L-SLNB to 
systemic sedation in patients undergoing oncological upper 
airway surgery can be considered safe and effective and 
induces a higher comfort status for AFOI.
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